EFFECT OF INTRAVENOUS LEVOSIMENDAN, A CALCIUM SENSITIZER, ON THE SURVIVAL OF HOSPITALIZED PATIENTS WITH HEART FAILURE Article Packer M., Nieminen M.S., Hasenfuss G., Follath F., Cleland J.GF., Moiseyev V.S., Lechat P., Pajunen P., Akkila J. Circulation. Lippincott Williams & Wilkins. Vol. 100. 1999. P. 646-646
HDL PHOSPHOLIPID: A NATURAL INHIBITOR OF ALZHEIMER'S AMYLOID BETA-FIBRILLOGENESIS? Article Koudinov A.R., Koudinova N.V., Berezov T.T., Ivanov Y.D. Clinical Chemistry and Laboratory Medicine. Vol. 37. 1999. P. 993-994